Kura Oncology, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kura Oncology, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Kura Oncology, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 77.8M shares, a 4.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 77.8M +3.49M +4.7% Nov 4, 2024 10-Q 2024-11-07
Q2 2024 76.6M +2.4M +3.23% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 76.2M +7.74M +11.3% Apr 26, 2024 10-Q 2024-05-02
Q3 2023 74.3M +7.38M +11% Oct 26, 2023 10-Q 2023-11-02
Q2 2023 74.2M +7.34M +11% Aug 3, 2023 10-Q 2023-08-09
Q1 2023 68.4M +1.8M +2.71% May 4, 2023 10-Q 2023-05-10
Q3 2022 66.9M +341K +0.51% Oct 27, 2022 10-Q 2022-11-03
Q2 2022 66.9M +597K +0.9% Jul 29, 2022 10-Q 2022-08-03
Q1 2022 66.6M +362K +0.55% Apr 29, 2022 10-Q 2022-05-04
Q3 2021 66.6M +9.85M +17.4% Nov 1, 2021 10-Q 2021-11-04
Q2 2021 66.3M +10M +17.8% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 66.3M +20.8M +45.9% May 3, 2021 10-Q 2021-05-06
Q3 2020 56.7M +11.4M +25.1% Nov 2, 2020 10-Q 2020-11-05
Q2 2020 56.3M +11.1M +24.5% Aug 3, 2020 10-Q 2020-08-06
Q1 2020 45.4M +7.27M +19% Apr 30, 2020 10-Q 2020-05-04
Q3 2019 45.3M +7.28M +19.1% Nov 1, 2019 10-Q 2019-11-05
Q2 2019 45.2M +7.24M +19.1% Jul 30, 2019 10-Q 2019-08-01
Q1 2019 38.2M +4.82M +14.4% Mar 1, 2019 10-K 2019-03-05
Q3 2018 38M +7.82M +25.9% Oct 31, 2018 10-Q 2018-11-05
Q2 2018 38M +16.6M +77.7% Aug 3, 2018 10-Q 2018-08-06
Q1 2018 33.4M +12M +56% Mar 9, 2018 10-K 2018-03-12
Q3 2017 30.2M +8.85M +41.4% Nov 3, 2017 10-Q 2017-11-07
Q2 2017 21.4M +6.96K +0.03% Aug 2, 2017 10-Q 2017-08-07
Q1 2017 21.4M +14.3K +0.07% Mar 10, 2017 10-K 2017-03-14
Q3 2016 21.4M -2.81K -0.01% Nov 2, 2016 10-Q 2016-11-07
Q2 2016 21.4M +6.86M +47.3% Aug 4, 2016 10-Q 2016-08-10
Q1 2016 21.4M +16.4M +327% Mar 11, 2016 10-K 2016-03-17
Q3 2015 21.4M +16.4M +327% Nov 13, 2015 10-Q 2015-11-13
Q2 2015 14.5M +9.51M +190% Aug 12, 2015 10-Q 2015-08-14
Q1 2015 5M 0 0% Feb 27, 2015 10-K 2015-02-27
Q3 2014 5M 0 0% Nov 14, 2014 10-Q 2014-11-14
Q2 2014 5M 0 0% Aug 14, 2014 10-Q 2014-08-14
Q1 2014 5M 0 0% Mar 31, 2014 10-K 2014-03-31
Q3 2013 5M 0 0% Nov 14, 2013 10-Q 2013-11-14
Q2 2013 5M 0 0% Aug 14, 2013 10-Q 2013-08-14
Q1 2013 5M 0 0% Mar 28, 2013 10-K 2013-03-28
Q3 2012 5M 0 0% Nov 14, 2012 10-Q 2012-11-14
Q2 2012 5M 0 0% Aug 14, 2012 10-Q 2012-08-14
Q1 2012 5M May 15, 2012 10-Q 2012-05-15
Q4 2011 0 Dec 31, 2011 10-K 2012-03-30
Q3 2011 5M Nov 14, 2011 10-Q 2011-11-14
Q2 2011 5M Aug 9, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.